Revolution Medicines, Inc. — Form 10-Q
Filed November 4, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
Revolution Medicines, Inc. (tenant) executed a 180-month lease with 1600 Seaport Owner, LLC (landlord) for the entire building at 1600 Seaport Boulevard, Redwood City, CA—283,015 rentable square feet. The lease commenced August 26, 2026 (execution date), with a commencement date approximately 13 months later. Base rent is redacted ([***]), along with tenant improvement allowance and letter of credit amounts. Tenant has three 60-month renewal options at fair market rent. The lease includes rent abatement for the first [***] months, operating expense/tax/insurance pass-throughs, and comprehensive tenant obligations for maintenance, hazardous materials handling, and insurance.
Why this rating
Large real estate commitment (~$6.7B company market cap) but represents normal course of business infrastructure. Lease terms are standard; no transformational financial impact evident from redacted amounts. Routine corporate facilities transaction.
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.